Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank85
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$1.12M
↑ 101% vs avg
Percentile
P85
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-75.16M
Historical baseline
PeriodValueYoY Change
TTM$1.12M+100.8%
2024$-148.61M-26.6%
2023$-117.35M+48.7%
2022$-228.82M-3521.3%
2021$6.69M+107.1%
2020$-93.61M-22.3%
2019$-76.52M-21.7%
2018$-62.85M+16.8%
2017$-75.52M-272.0%
2016$43.92M-